Get Used to Living Longer
We’re family-owned and operated with a 70-year history of bringing life-prolonging therapies to patients who need them most.
Contact Us
People Are Our Mission
It starts with close relationships with our patients, physicians, and a global commitment to provide premium healthcare for all.
Discover Our Difference
Uncommon Pursuit
We’re addressing unmet needs through novel preparations and orphan drugs, and relentlessly building a pipeline of treatments in cardiology, ophthalmology, and urology.
Find Out MoreAGEPHA Pharma in the News
U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease
LODOCO® (colchicine, 0.5 mg tablets) reduces cardiac event risk in adult patients with established Atherosclerotic Cardiovascular Disease (ASCVD) by an additional 31% on top of standard of care including high intensity statins.
Late-Breaking Clinical Trial Presented at the American College of Cardiology
Supports Low-Dose Colchicine, 0.5 mg to Treat Cardiovascular Disease by Reducing Progression of Coronary Plaque